Therapeutic Solutions International, Inc.
TSOI · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $20 | $20 | $22 | $24 |
| % Growth | -1.7% | -8.3% | -8.5% | – |
| Cost of Goods Sold | $4 | $7 | $7,490 | $189 |
| Gross Profit | $15 | $13 | $14 | -$165 |
| % Margin | 77.6% | 66.4% | 65.7% | -693.9% |
| R&D Expenses | $16 | $18 | $58,612 | $151 |
| G&A Expenses | $1,959 | $296 | $258,456 | $420 |
| SG&A Expenses | $1,959 | $400 | $258,456 | $241 |
| Sales & Mktg Exp. | $0 | $104 | $0 | -$179 |
| Other Operating Expenses | $0 | $0 | -$316,380 | $0 |
| Operating Expenses | $1,975 | $417 | $688 | $391 |
| Operating Income | -$1,960 | -$404 | -$673 | -$557 |
| % Margin | -9,963.5% | -2,019.7% | -3,086.3% | -2,336.1% |
| Other Income/Exp. Net | -$76 | -$60 | -$91 | $78 |
| Pre-Tax Income | -$2,035 | -$464 | -$764 | -$479 |
| Tax Expense | -$1,027,893 | $1 | $0 | $1 |
| Net Income | -$1,008 | -$390 | -$585 | -$427 |
| % Margin | -5,123% | -1,949.7% | -2,682.4% | -1,793.7% |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | -100% | 0% | 0% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 4,913,103 | 4,511,799 | 3,953,546 | 3,802,667 |
| Weighted Avg Shares Out Dil | 4,913,103 | 4,511,799 | 3,953,546 | 3,802,667 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $106 | $74 | $89 | $96 |
| Depreciation & Amortization | $77 | $77 | $77 | $81 |
| EBITDA | -$1,852 | -$313 | -$598 | -$302 |
| % Margin | -9,417.6% | -1,562.7% | -2,742.1% | -1,267.5% |